Version 2.73

59822-7Tacrolimus [Mass/volume] in Serum or Plasma --4 hours post doseActive

Part Descriptions

LP15182-6   Tacrolimus
Tacrolimus (also known as FK-506 or Prograf) is a macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis. It has strong immunosuppressive properties and is commonly used to prevent allograft rejection in transplant recipients. One of its modes of action is to prevent T-lymphocyte activation. Source: National Library of Medicine, MeSH 2006

LP15182-6   Tacrolimus
Tacrolimus (also called FK-506 or fujimycin, Prograf, Advagraf, or Protopic) is amacrolide lactone, calcineurin inhibitor immunosuppresent used mainly after allogeneic organ transplant to lower the risk of organ rejection. It possesses strong immunosuppressive activity by preventing the activation by of T-lymphocytes in response to antigenic or mitogenic stimulation. Tacrolimus is also used in a topical preparation in the treatment of atopic dermatitis (eczema), severe refractory uveitis after bone marrow transplants, exacerbations of minimal change disease, TH2-mediated diseases such as Kimura's disease, and the skin condition vitiligo. There are potentially severe side effects from doses that are either too low or too high; inadequate tacrolimus concentrations may result in rejection of the transplanted organ, while high levels may lead to severe adverse effects includin nephrotoxicity, neurotoxicity, gastrointestinal disturbances, diabetogenesis, hypertension and malignant complications. [Wikipedia:Tacrolimus] Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Tacrolimus

Fully-Specified Name

Tacrolimus^4H post dose

Additional Names

Short Name
Tacrolimus 4h p SerPl-mCnc
Display Name
Tacrolimus 4 Hr post dose [Mass/Vol]
Consumer Name Alpha
Tacrolimus 4 hr after dose, Blood

Basic Attributes

First Released
Version 2.32
Last Updated
Version 2.70
Order vs. Observation

Member of these Groups

LG50875-0 Tacrolimus^4H post dose|MCnc|Pt|ANYBldSerPl

Language Variants Get Info

zh-CNChinese (China)
nl-NLDutch (Netherlands)
tacrolimus^4 uur na dosis:massa/volume:moment:serum of plasma:kwantitatief:
et-EEEstonian (Estonia)
Takroliimus^4 tundi pärast annust:MCnc:Pt:S/P:Qn:
fr-BEFrench (Belgium)
Tacrolimus^4 h post dose:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif:
fr-CAFrench (Canada)
Tacrolimus^4 h post dose:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif:
fr-FRFrench (France)
Tacrolimus T04h après administration:Masse/Volume:Ponctuel:Sérum/Plasma:Numérique:
it-ITItalian (Italy)
Tacrolimus^4h post dose:MCnc:Pt:Siero/Plasma:Qn:
pt-BRPortuguese (Brazil)
Tacrolimus^240 min após dose::Pt:Soro/Plas:Qn:
ru-RURussian (Russian Federation)
Такролимус^4 часа после дозы:МассКонц:ТчкВрм:Сыв/Плаз:Колич:
es-MXSpanish (Mexico)
Tacrolimus ^4 horas después de la dosis:Concentración de masa:Punto temporal:Suero o Plasma:Cuantitativo:
es-ESSpanish (Spain)
Tacrolimus^4H pos dosis:Concentración de masa:Punto temporal:Suero o Plasma:Qn:
tr-TRTurkish (Turkey)
Takrolimus^4Sa snr doz:KütlKons:Zmlı:Ser/Plaz:Kant:

Example Units

Unit Source
ug/L Example UCUM Units

LOINC FHIR® API Example - CodeSystem Request Get Info